BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 31425628)

  • 1. Statins versus placebo for people with chronic obstructive pulmonary disease.
    Walsh A; Perrem L; Khashan AS; Henry MT; Ni Chroinin M
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011959. PubMed ID: 31425628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
    Janjua S; Fortescue R; Poole P
    Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Normansell R; Maisey S; Poole P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
    Fraser A; Poole P
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013343. PubMed ID: 36373977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aclidinium bromide for stable chronic obstructive pulmonary disease.
    Ni H; Soe Z; Moe S
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010509. PubMed ID: 25234126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).
    Janjua S; Pike KC; Carr R; Coles A; Fortescue R; Batavia M
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013381. PubMed ID: 34496032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.
    Ni H; Aye SZ; Naing C
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013506. PubMed ID: 35616126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease.
    Gendron LM; Nyberg A; Saey D; Maltais F; Lacasse Y
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012290. PubMed ID: 30306545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Sathananthan K; Fortescue R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009552. PubMed ID: 26391969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled corticosteroids versus placebo  for stable chronic obstructive pulmonary disease.
    Yang IA; Ferry OR; Clarke MS; Sim EH; Fong KM
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD002991. PubMed ID: 36971693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease.
    Threapleton CJ; Janjua S; Fortescue R; Baker EH
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013024. PubMed ID: 31125127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009552. PubMed ID: 24043433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Kew KM; Mavergames C; Walters JA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.